Showing results (41-50 of 49) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 49 results.
Cancer Medicine|February 5, 2020
Characterization of the immune microenvironment in brain metastases from different solid tumorsJinling Jiang, Lihong Wu, Fei Yuan, et al.
Anti-Cancer Agents in Medicinal Chemistry|September 1, 2012
Oncogenic miR-544 is an important molecular target in gastric cancerQiaoming Zhi, Xiaobo Guo, Lei Guo, et al.
Future Oncology (London, England)|December 3, 2025
A multicenter, observational study to evaluate the safety of restarting antitumor therapy recovered from COVID-19Liting Guo, Chenfei Zhou, Wenqi Xi, et al.
International Journal of Biological Sciences|May 20, 2026
GLUT3 drives paclitaxel resistance in peritoneal metastatic gastric cancer by promoting H3K18 lactylation-mediated MAPKAP1 transcription to suppress ferroptosisYing Sun, Xirui Duan, Benyan Zhang, et al.
Molecular Cancer|October 25, 2024
A multidimensional recommendation framework for identifying biological targets to aid the diagnosis and treatment of liver metastasis in patients with colorectal cancerFeng Qi, Na Gao, Jia Li, et al.
Oncotarget|September 3, 2016
A characteristic biosignature for discrimination of gastric cancer from healthy population by high throughput GC-MS analysisYinan Chen, Jun Zhang, Lei Guo, et al.
Frontiers in Immunology|October 23, 2025
Clinical and body composition parameters as predictors of response to chemotherapy plus PD-1 inhibitor in gastric cancerChenfei Zhou, Yan Sun, Tao Liu, et al.
Clinical Epigenetics|August 23, 2025
Landscape analysis of m5C modification regulators unveils DNMT1-mediated dysregulated pyrimidine metabolism in hepatocellular carcinomaXuhui Zhao, Shengwei Mao, Yuan Fang, et al.
BMC Medicine|October 22, 2025
Lipid metabolism associated with efficacy of metronomic capecitabine and camrelizumab in gastrointestinal cancer: an exploratory clinical trialChenfei Zhou, Yuanyuan Yin, Chengfang Shangguan, et al.
Pageof 5